HLA-DRB1 and myeloid sarcoma: The findings from this colocalisation assessment suggested a probable shared causal variant between MS susceptibility and two prominent genes, namely HLA‐DRB1 and SYK, with posterior probabilities exceeding 0.80% (HLA‐DRB1: 100.00%, SYK: 97.93%) (refer to Table 4).